Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |